Amazentis SA
37Patents
37Active
37Granted
55Portfolio score
Filing activity: Jul 23, 2010 → Jan 19, 2024 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9872850B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 12 | Active |
| US8933217B2 | Compounds, compositions, and methods for protecting brain health in neurodegenerative disorders | Human Necessities | 11 | Active |
| US10485782B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 10 | Active |
| US10028932B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 9 | Active |
| US10857126B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 8 | Active |
| US9962366B2 | Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof | Chemistry; Metallurgy | 7 | Active |
| US10988453B2 | Compositions comprising an urolithin compound | Human Necessities | 7 | Active |
| US9994542B2 | Prodrugs of urolithins and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US11166972B2 | Compositions comprising nicotinamide riboside and a urolithin | Human Necessities | 6 | Active |
| US11234960B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 6 | Active |
| US11166937B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 6 | Active |
| US10442784B2 | Compositions comprising an urolithin compound | Human Necessities | 6 | Active |
| US10792276B2 | Urolithins as immune response enhancers | Emerging Cross-Sectional Technologies | 5 | Active |
| US10695320B2 | Compositions comprising urolithin compounds | Chemistry; Metallurgy | 5 | Active |
| US10532992B2 | Prodrugs of urolithins and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US10906883B2 | Process-scale synthesis of urolithin A | Performing Operations; Transporting | 5 | Active |
| US11020373B2 | Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof | Chemistry; Metallurgy | 5 | Active |
| US11180468B2 | Prodrugs of urolithins and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US9394269B2 | Process-scale synthesis of urolithins | Human Necessities | 4 | Active |
| US9573922B2 | Process-scale synthesis of urolithins | Human Necessities | 3 | Active |
| US9980980B2 | Compounds, compositions and methods for protecting brain health in neurodegenerative disorders | Human Necessities | 3 | Active |
| US12036205B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 1 | Active |
| US11878964B2 | Compositions comprising an urolithin compound | Human Necessities | 1 | Active |
| US11634401B2 | Process-scale synthesis of urolithin A | Performing Operations; Transporting | 1 | Active |
| US11903922B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.